Home › Funds › Sio Capital Management, LLC › BMRN

Sio Capital Management, LLC position in BMRN

BIOMARIN PHARMACEUTICAL INC · Health Care

Sio Capital Management, LLC reported holding 174,311 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$10.5M, representing 2.06% of its reported portfolio and ranking #19 among its reported holdings. Sio Capital Management, LLC has disclosed BMRN holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)174.31K sh
Reported value held$10.46M
Portfolio Weight2.06%
First reportedQ1 2025
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Sio Capital Management, LLC's BMRN position evolved

Sio Capital Management, LLC first disclosed a stake in BMRN in Q1 2025 at 141,134 shares (US$10.0M). The position peaked in Q4 2025 at 232,688 shares, worth US$13.8M. Across 6 filings, Sio Capital Management, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 174,311 shares valued at US$10.5M. Notable position changes include a 60% increase in Q2 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 141.13K $9.98M New
Q2 2025 225.11K $12.37M Add
Q3 2025 225.11K $12.19M Hold
Q4 2025 232.69K $13.83M Add
Q1 2026 194.23K $10.97M Reduce
Q3 2026 174.31K $10.46M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Sio Capital Management, LLC held BMRN?

Sio Capital Management, LLC has disclosed BMRN holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

What is Sio Capital Management, LLC's current position in BMRN?

As of Q3 2026, Sio Capital Management, LLC holds 174.31K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $10.46M, representing 2.06% of its reported portfolio and ranking #19.

Has Sio Capital Management, LLC been buying or selling BMRN?

In the latest 13F filing (Q3 2026), Sio Capital Management, LLC newly opened its position in BMRN. The position peaked in Q4 2025 at 232.69K shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.